• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee

 

FDA 

 

Disclaimer

 

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. ยง 552).

 

FDA Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF - 11MB)

 

Errata to the FDA Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF - 60KB)

 

 

Salix Pharmaceuticals, Inc

 

Disclaimer

 

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

Salix Pharmaceuticals Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF - 2MB)

 

Errata to the Salix Pharmaceuticals Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF - 78KB)